1-3 of 3
Richard Greil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

Adam J. Olszewski, Tycel J. Phillips, Marc S. Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason Westin, Izidore S. Lossos, Javier L. Munoz, Jason Sit, Michael C. Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L. Yee, Ulrich Jaeger
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6055–6065.
https://doi.org/10.1182/bloodadvances.2023010840
Published: 2023
Includes: Supplemental data
Journal Articles

Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study

Clinical Trials & Observations
Olga Oleshko, Sonja Werwitzke, Annika Klingberg, Torsten Witte, Hermann Eichler, Robert Klamroth, Katharina Holstein, Christina Hart, Christian Pfrepper, Paul Knöbl, Richard Greil, Peter Neumeister, Birgit M. Reipert, Andreas Tiede
Journal: Blood Advances
Blood Adv (2023) 7 (1): 122–130.
https://doi.org/10.1182/bloodadvances.2022008071
Published: 2023
Journal Articles

Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

Clinical Trials & Observations
Sophie Bernard, Herve Ghesquieres, Rene-Olivier Casasnovas, Samuel Griolet, Maria Gomes da Silva, Pierre Feugier, Franck Morschhauser, Judith Trotman, Loic Renaud, Richard Greil, Alejandro Martín García-Sancho, Sebastian Grosicki, Koen van Eygen, Christiane Copie-Bergman, Corinne Haioun, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2965–2968.
https://doi.org/10.1182/bloodadvances.2021004766
Published: 2021
Includes: Supplemental data